uniQure (QURE) Long-Term Investments (2022 - 2026)
uniQure (QURE) recorded quarterly Long-Term Investments of $30.2 million in Q1 2026, little changed quarter-over-quarter from $30.2 million in Q4 2025, and up 6.64% on a YoY basis from $28.3 million in Q1 2025.
uniQure (QURE) Long-Term Investments (2022 - 2026) Analysis & Trends
uniQure's Long-Term Investments history runs 5 years deep, the most recent figure standing at $30.2 million for Q1 2026.
- In Q1 2026, Long-Term Investments rose 6.64% year-over-year to $30.2 million; the TTM figure through Mar 2026 stood at $30.2 million (up 6.64% YoY), while the FY2025 annual figure was $30.2 million, up 10.1% from the prior year.
- Long-Term Investments was $30.2 million for Q1 2026 at uniQure, roughly flat from $30.2 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $40.0 million in Q4 2022 to a low of $2.2 million in Q4 2023.
- Historically, Long-Term Investments has averaged $27.4 million across 5 years, with a median of $29.7 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Long-Term Investments slumped 94.55% in 2023, then surged 1160.39% in 2024.
- A 5-year view of Long-Term Investments shows it stood at $40.0 million in 2022, then plunged by 94.55% to $2.2 million in 2023, then soared by 1160.39% to $27.5 million in 2024, then gained by 10.1% to $30.2 million in 2025, then slipped by 0.29% to $30.2 million in 2026.
- The last three Long-Term Investments figures came in at $30.2 million (Q1 2026), $30.2 million (Q4 2025), and $30.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 30.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.15 Mn |
| Dec 31, 2025 | 30.24 Mn |
| Sep 30, 2025 | 29.97 Mn |
| Jun 30, 2025 | 29.74 Mn |
| Mar 31, 2025 | 28.27 Mn |
| Dec 31, 2024 | 27.46 Mn |
| Sep 30, 2024 | 28.26 Mn |
| Dec 31, 2023 | 2.18 Mn |
| Dec 31, 2022 | 39.98 Mn |